digital currency blog Top Featured

Shennong Group has set up a new trading subsidiary in Guangxi. The enterprise search APP shows that recently, Guangxi Shennong Haiyun Trading Co., Ltd. was established, with the legal representative of He Xinyang and the registered capital of 10 million yuan. Its business scope includes: electronic product sales; Non-metallic minerals and products sales; Building materials sales, etc. Enterprise equity penetration shows that the company is wholly owned by Shennong Group.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.Actually, Zhijia has set up a new company to sell new energy vehicles. The enterprise search APP shows that recently, Beijing Dongwo Retail Co., Ltd. was established, with the legal representative of Li Jie and the registered capital of 10 million yuan. Its business scope includes: automobile sales; New energy vehicle sales; Wholesale of auto parts; Sales of electrical accessories for new energy vehicles; Sales of power exchange facilities for new energy vehicles. Enterprise investigation shows that the company is indirectly wholly-owned by Juran Zhijia.

China Petroleum and others set up a joint exploration company in Xinjiang with a registered capital of 1 billion yuan. According to the enterprise search APP, PetroChina Tayou Joint Exploration (Xinjiang) Co., Ltd. was recently established, with the legal representative of Liu Weibo and a registered capital of 1 billion yuan. Its business scope includes: mineral resources exploration. Enterprise survey shows that the company is jointly owned by PetroChina Taihu (Beijing) Investment Co., Ltd., a wholly-owned subsidiary of China Petroleum, and Xinjiang Yaxin CBM Investment and Development (Group) Co., Ltd.Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation. On December 12th, Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation, including the cooperation project of Xiong 'an Medical and Industrial Cross Transformation Research Institute of Peking University People's Hospital and the fourth generation semiconductor material doped AlN epitaxial wafer, and many independent innovative projects landed in xiong'an new area. As a national innovation platform, Xiong 'an Center will focus on key tasks such as building a first-class innovation platform, forming a composite innovation team, and improving the innovation and entrepreneurship ecology, and strive to create an important source of independent innovation and original innovation. (CCTV News)The ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project entered the commissioning stage, and ExxonMobil China announced that in December 2024, the 1.6 million tons ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project was handed over to China and entered the commissioning stage in an all-round way. ExxonMobil Huizhou Ethylene Project is located in Huizhou Daya Bay Petrochemical Park. The first phase of the project mainly includes ethylene plants, high-end polyethylene and polypropylene production plants in the middle and lower reaches, and supporting utilities, docks, storage and transportation and environmental protection facilities.

Xi 'an Aisheng Group: It is planned to conduct a comprehensive benchmarking survey on financial and internal control according to the asset securitization standards, and the Ordnance Industry Group issued the Comprehensive Financial and Audit Services Project of Xi 'an Aisheng Technology Group Co., Ltd. on the procurement e-commerce platform. The announcement shows that the project will conduct a comprehensive benchmarking survey on the purchaser's financial and internal control situation in accordance with the asset securitization standards, put forward rationalization suggestions, and issue a best-effort report. At the same time, review the annual financial statements of the purchaser during the standardized period, and assist the purchaser to complete the annual final accounts and tax returns; Cooperate with other intermediaries in their daily work. According to the requirements, the supplier must have the audit performance of similar asset securitization projects undertaken since January 1, 2021, and the project leader must have the successful project performance signed by two or more audit reports of similar asset securitization projects. According to the data, Xi 'an Aisheng Group is one of the earliest units engaged in the development and production of UAV systems in China. In 2009, 2017 and 2019, the developed products participated in the military parade of the 60th anniversary of the National Day, the 90th anniversary of the founding of the People's Republic of China and the 70th anniversary of the National Day. In addition, Inner Mongolia No.1 Machinery Co., Ltd. (600967), which is also a subsidiary of China Ordnance Industry Group, just announced on December 7 that it plans to increase its capital with related parties. Upon completion, the company will hold 4.27% of its shares, and together with the actual controller China Ordnance Industry Group and concerted parties, it will hold 52.15% of its shares.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.Hang Seng Science and Technology Index rose to 1%, while Kewang shares rose, with Billie Billie (09626.HK) rising by over 4%, Baidu (09888.HK) rising by 2.8%, Aauto Quicker (01024.HK), Tencent Holdings (00700.HK) rising by 1.8% and Alibaba (09988.HK) rising by over 1%.